跳至主要内容
临床试验/EUCTR2018-001601-82-NL
EUCTR2018-001601-82-NL进行中(未招募)1 期

Open randomized clinical trial to compare pain relief between low-dose methoxyflurane and standard of care for the treatment of patients with trauma pain in emergency medical services in the Netherlands. - Low-dose MEOF vs SoC for trauma pain in emergency medical services

Mundipharma Pharmaceuticals B.V.0 个研究点目标入组 300 人开始时间: 2018年12月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Patients should be = 18 years of age
  • -Moderate pain (NRS0-10 =4 and =8) secondary to extremity injuries
  • -Conscious patients with a stable circulation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 300
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Hypersensitivity to MEOF or any fluorinated anaesthetic.
  • -Malignant hyperthermia: patients with known or genetically susceptible to malignant hyperthermia or a history of severe adverse reactions in either patient or relatives.
  • -Patients who have a history of showing signs of liver damage after previous MEOF use or halogenated hydrocarbon anaesthesia
  • -Known clinically significant renal impairment
  • -Known pregnant or likely to be pregnant women at the time of inclusion.
  • -Clinically evident cardiovascular instability
  • -Clinically evident respiratory depression
  • -Patients taken any analgesic (excluding oral WHO-step 1 analgesics) for the trauma pain before inclusion
  • -Altered level of consciousness due to any cause, including head injury, drugs or alcohol
  • - Active alcohol or drug abuse and/or history of opioid abuse
  • -Degenerative diseases, mental illness or other conditions that could affect ability of valuing pain intensity
  • -Patients unable to understand the purpose of the study and perform self-assessments, following investigator’s criteria.
  • -Participation in another clinical trial within 30 days prior to randomization.

研究者

相似试验